# Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study

Source: https://onco.cc/trials/nct05067530/  
OnCo record `nct05067530` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of palbociclib, paclitaxel / nab-paclitaxel and carboplatin in triple-negative breast cancer, run by Medical University of Gdansk, not yet recruiting.

## Summary

Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study is a phase 2, randomised interventional study registered as NCT05067530 by Medical University of Gdansk, with a registry enrolment figure of 126 participants, started 2022-01-01 and due to reach its primary completion in 2025-01-01. Interventions recorded: Palbociclib; Paclitaxel; Carboplatin. Conditions listed: Triple Negative Breast Neoplasms. Triple-negative eligibility wording from the registry: "* triple negative tumor defined as:". Sites: Poland. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: CAREGIVER
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT05067530
- Phase: 2
- Setting: Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study
- Sponsor: Medical University of Gdansk
- Enrolled: 126

## Sources

- ClinicalTrials.gov NCT05067530: https://clinicaltrials.gov/study/NCT05067530

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Palbociclib](https://onco.cc/drugs/palbociclib/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05067530.json